US-based Novavax, Inc. and Serum Institute of India have announced that the Thailand Food and Drug Administration (Thai ...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and NEC Corporation in Japan have announced the ...
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical p...
CanSino Biologics has announced that the National Medical Products Administration of China (NMPA) granted approval for t...
A potential new approach to administering an existing Japanese encephalitis (JE) vaccine could make it more affordable a...
Singapore-based Prestige Biopharma and Vaxine have entered into a memorandum of understanding (MoU) to collabo...
Melbourne researchers are calling on healthy people aged 18-70 living in Victoria to roll up their sleeves for a Phase 1...
The Expert Committee on COVID-19 Vaccination (EC19V) in Singapore has been closely reviewing the data regarding the need...
The Australian government is investing more than $100 million for seasonal influenza vaccines to protect Aus...
The state of Victoria (Australia) and Korea have signed a Memorandum of Understanding (MoU) to collaborate on mRNA vacci...
Around 400 of Asia’s renowned Biopharmaceutical manufacturing and logistics leadership personnel will gather in-pe...
Denmark's Bavarian Nordic has entered into an exclusive license and supply agreement with Nuance Pharma, a Shanghai-base...
A group of scientists at the University of Auckland in New Zealand are working towards developing an mRNA-based vaccine ...
What are the unique highlights of the COVID-19 vaccine- VLA2001 under trial? While different companies have taken vario...
Sinovac Biotech, based in China, has signed a letter of agreement with the Ecuadorian Ministry of Public Healt...
The World Health Organization (WHO), the Republic of Korea and the WHO Academy have announced the establishment of a glo...
The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway and the Murdoch Children’s Research Institute...
CanSino Biologics Inc. has announced that its Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector)...
